Have a personal or library account? Click to login
Synthesis and anti-tumor evaluation of novel hydrazide and hydrazide-hydrazone derivatives Cover

Synthesis and anti-tumor evaluation of novel hydrazide and hydrazide-hydrazone derivatives

Open Access
|Mar 2013

References

  1. 1. S. K. Bharti, G. Nath, R. Tilak and S. K. Singh, Synthesis, anti-bacterial and anti-fungal activities of some novel Schiff bases containing 2,4-disubstituted thiazole ring, Eur. J. Med. Chem. 45 (2010) 651-660; DOI: 10.1016/j.ejmech.2009.11.008.10.1016/j.ejmech.2009.11.008
  2. 2. C. Loncle, J. M. Brunel, N. Vidal, M. Dherbomez and Y. Letourneux, Synthesis and antifungal activity of cholesterol-hydrazone derivatives, Eur. J. Med. Chem. 39 (2004) 1067-1071; DOI: 10.1016/ j.ejmech.2004.07.005.10.1016/j.ejmech.2004.07.005
  3. 3. S. P. Garoufalias, N. Pouli, P. Marakos and A. C. Ladas, Synthesis, antimicrobial and antifungal activity of some new 3-substituted derivatives of 4-(2,4-dichlorophenyl)-5-adamantyl-1H-1,2,4- -triazole, Farmaco 57 (2002) 973-977; DOI: 10.1016/S0014-827X(02)01273-9.10.1016/S0014-827X(02)01273-9
  4. 4. P. Vicini, F. Zani, P. Cozzini and I. Doytchinova, Hydrazones of 1,2-benzisothiazole hydrazides: synthesis, antimicrobial activity and QSAR investigations, Eur. J. Med. Chem. 37 (2002) 553-567; DOI: 10.1016/S0223-5234(02)01378-8.10.1016/S0223-5234(02)01378-8
  5. 5. F. D. Popp, Potential anticonvulsant. XII. Anticonvulsant activity of some aldehyde derivatives, Eur. J. Med. Chem. 24 (1989) 313-316; DOI: 10.1016/0223-5234(89)90016-0.10.1016/0223-5234(89)90016-0
  6. 6. S. K. Sridhar, S. N. Pandeya, J. P. Stables and R. Atmakuru, Anticonvulsant activity of hydrazones, Schiff and Mannich bases of isatin derivatives, Eur. J. Pharm. Sci. 16 (2002) 129-132; DOI: 10.1016/S0928-0987(02)00077-5.10.1016/S0928-0987(02)00077-5
  7. 7. S. G. Küçükgüzel, S. Rollas, I. Küçükgüzel and M. Kiraz, Synthesis and antimycobacterial activity of some coupling products from 4-aminobenzoic acid hydrazones, Eur. J. Med. Chem. 34 (1999) 1093-1100; DOI: 10.1016/S0223-5234(99)00129-4.10.1016/S0223-5234(99)00129-4
  8. 8. B. K. Kaymakçýoǧlu and S. Rollas, Synthesis, characterization and evaluation of antituberculosis activity of some hydrazones, Farmaco 57 (2002) 595-599; DOI: 10.1016/S0014-827X(02)01255-7.10.1016/S0014-827X(02)01255-7
  9. 9. S. G. Küçükgüzel, A. Mazi, F. Sahin, S. Öztürk and J. P. Stables, Synthesis and biological activities of diflunisal hydrazide-hydrazones, Eur. J. Med. Chem. 38 (2003) 1005-1013; DOI: 10.1016/ j.ejmech.2003.08.004.10.1016/j.ejmech.2003.08.004
  10. 10. A. R. Todeschini, A. L. P. de Miranda, K. C. M. da Silva, S. C. Parrini and E. Barreiro, Synthesis and evaluation of analgesic, antiinflammatory and antiplatelet properties of new 2-pyridylarylhydrazone derivatives, Eur. J. Med. Chem. 33 (1998) 189-199; DOI: 10.1016/S0223-5234(98)80008-1.10.1016/S0223-5234(98)80008-1
  11. 11. M. A. Gaston, L. R. S. Dias, A. C. C. Freitas, A. L. P. Miranda and E. J. Barreiro, Synthesis and analgesic properties of new 4-arylhydrazone 1H pyrazole[3,4-b]pyridine derivatives, Pharm. Acta Helv. 71 (1996) 213-219; DOI: 10.1016/0031-6865(96)00012-X.10.1016/0031-6865(96)00012-X
  12. 12. P. Melnyk, V. Leroux, C. Sergheraert and P. Grellier, Design, synthesis and in vitro antimalarial activity of an acylhydrazone library, Bioorg. Med. Chem. Lett. 16 (2006) 31-35; DOI: 10.1016/j.bmcl. 2005.09.058.
  13. 13. N. Terzioglu and A. Gursoy, Synthesis and anticancer evaluation of some new hydrazone derivatives of 2,6-dimethylimidazo[2,1-b][1,3,4]thiadiazole-5-carbohydrazide, Eur. J. Med. Chem. 38 (2003) 781-786; DOI: 10.1002/chin.200401111.10.1002/chin.200401111
  14. 14. S. M. Sondhi, M. Dinodia and A Kumar, Synthesis, anti-inflammatory and analgesic activity evaluation of some amidine and hydrazone derivatives, Bioorg. Med. Chem. 14 (2006) 4657-4663; DOI: 10.1016/j.bmc.2006.02.014.10.1016/j.bmc.2006.02.014
  15. 15. C. Boga, L. Fiume, M. Baglioni, C. Bertucci, C. Farina, F. Kratz, M. Manerba, M. Naldi and G. Stefano, Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy, Eur. J. Pharm. Sci.38 (2009) 262-269; DOI: 10.1016/j.ejps.2009.08.001.10.1016/j.ejps.2009.08.001
  16. 16. M. C. Garnett, Targeted drug conjugates: principles and progress, Adv. Drug Deliv. Rev. 53 (2001) 171-216; DOI: 10.1016/S0169-409X(01)00227-7.10.1016/S0169-409X(01)00227-7
  17. 17. P. C. Rodrigues, K. Scheuermann, C. Stockmar, G. Maier, H. Fiebig, C. Unger, R. Mülhaupt and F. Kratz, Synthesis and in-vitro efficacy of acid-sensitive poly(ethylene glycol) paclitaxel conjugates, Bioorg. Med. Chem. Lett. 13 (2003) 355-360; DOI: 10.1016/S0960-894X(02)01002-8.10.1016/S0960-894X(02)01002-8
  18. 18. O. I. El-Sabbagh and H. M. Rady, Synthesis of new acridines and hydrazones derived from cyclic â-diketone for cytotoxic and antiviral evaluation, Eur. J. Med. Chem. 44 (2009) 3680-3686; DOI: 10.1002/chin.200948062.10.1002/chin.200948062
  19. 19. H. Krakovicova, T. Etrych and K. Ulbrich, HPMA-based polymer conjugates with drug combination, Eur. J. Pharm. Sci. 37 (2009) 405-412; DOI: 10.1016/j.ejps.2009.03.011.10.1016/j.ejps.2009.03.01119491032
  20. 20. H. Z. Zhang, J. Drewe, B. Tseng, S. Kasibhatla and S. X. Cai, Discovery and SAR of indole-2- -carboxylic acid benzylidene-hydrazides as a new series of potent apoptosis inducers using a cell-based HTS assay, Bioorg. Med. Chem. 12 (2004) 3649-3655; DOI: 10.1016/j.bmc.2004.04.017.10.1016/j.bmc.2004.04.01715186849
  21. 21. P. Vicini, M. I. Incerti, P. L. Colla and R. Loddo, Anti-HIV evaluation of benzo[d]isothiazole hydrazones, Eur. J. Med. Chem. 44 (2009) 1801-1807; DOI: 10.1016/j.ejmech.2008.05.030.10.1016/j.ejmech.2008.05.03018614259
  22. 22. V. M. Rahman, S. Mukhtar, W. H. Ansari and G. Lemiere, Synthesis, stereochemistry and biological activity of some novel long alkyl chain substituted thiazolidin-4-ones and thiazan-4-one from 10- undecenoic acsid hydrazide, Eur. J. Med. Chem. 40 (2005) 173-184; DOI: 10.1016/j.ejmech.2004. 10.003.
  23. 23. J. R. Dimmock, S. C. Vashishtha and J. P. Stables, Anticonvulsant properties of various acetylhydrazones, oxamoylhydrazones and semicarbazones derived from aromatic and unsaturated carbonyl compounds, Eur. J. Med. Chem. 35 (2000) 241-248; DOI: 10.1016/S0223-5234(00)00123-9.10.1016/S0223-5234(00)00123-9
  24. 24. D. Kaushik, S. A. Khan, G. Chawla and S. Kumar, N'-[5-chloro-3-methyl-1-phenyl-1H-pyrazol- -4-yl)methylene]2/4-substituted hydrazide: Synthesis and anticonvulsant activity, Eur. J. Med. Chem. 45 (2010) 3943-3949; DOI: 10.1016/j.ejmech.2010.05.049.10.1016/j.ejmech.2010.05.04920573423
  25. 25. S. G. Küçükgüzel, A. Mazi, F. Sahin, S. Öztürk and J. Stables, Synthesis and biological activities of diflunisal hydrazide-hydrazones, Eur. J. Med. Chem. 38 (2003) 1005-1013. DOI: 10.1016/ j.ejmech.2003.08.004.10.1016/j.ejmech.2003.08.00414642333
  26. 26. Y. L. Xia, F. Chuan-Dong, B. X. Zhao, J. Zhao, D. S. Shin and J. Y. Miaom, Synthesis and structure- activity relationships of novel 1-arylmethyl-3-aryl-1H pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells, Eur. J. Med. Chem. 43 (2008) 2347-2353; DOI: 10.1016/j.ejmech.2008.01.021.10.1016/j.ejmech.2008.01.02118313806
  27. 27. C. Menendez, A. Chollet, F. Rodriguez, C. Inard, M. R. Pasca, C. Lherbet and M. Baltas, Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents, Eur. J. Med. Chem. 52 (2012) 275-283; DOI: 10.1016/j.ejmech.2012.03.029.10.1016/j.ejmech.2012.03.02922483635
  28. 28. N. Özbek, S. Alyar and N. Karacan, Experimental and theoretical studies on methanesulfonic acid 1-methylhydrazide: Antimicrobial activities of its sulfonyl hydrazone derivatives, J. Mol. Struct. 938 (2009) 48-53; DOI: 10.1016/j.molstruc.2009.09.002.10.1016/j.molstruc.2009.09.002
  29. 29. R. M. Mohareb and J. Schatz, Anti-tumor and anti-leishmanial evaluations of 1,3,4-oxadiazine, pyran derivatives derived from cross-coupling reactions of b-bromo-6H-1,3,4-oxadiazine derivatives, Bioorg. Med. Chem. 19 (2011) 2707-2713; DOI: 10.1016/j.bmc.2011.02.051.10.1016/j.bmc.2011.02.05121435889
DOI: https://doi.org/10.2478/acph-2013-0004 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 45 - 57
Published on: Mar 12, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2013 Wagnat Wahba Wardakhan, El-Sayed Nahed Nasser Eid, Rafat Milad Mohareb, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.